Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Pelin

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Molecular Therapy Oncolytics|August 21, 2019
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer TherapyAdrian Pelin, Johann Foloppe, Julia Petryk, et al.
Nature Microbiology|October 10, 2018
Leveraging single-cell genomics to expand the fungal tree of lifeSteven R Ahrendt, C Alisha Quandt, Doina Ciobanu, et al.
Science Translational Medicine|January 5, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapyMarie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken, et al.
The New Phytologist|January 14, 2019
Comparative genomics of Rhizophagus irregularis, R. cerebriforme, R. diaphanus and Gigaspora rosea highlights specific genetic features in GlomeromycotinaEmmanuelle Morin, Shingo Miyauchi, Hélène San Clemente, et al.
Journal of Proteome Research|March 3, 2025
Affinity Purification Mass Spectrometry on the Orbitrap-Astral Mass Spectrometer Enables High-Throughput Protein-Protein Interaction MappingLia R Serrano, Adrian Pelin, Tabiwang N Arrey, et al.
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Frontiers in Molecular Biosciences|May 28, 2026
Tumor-directed evolution of VSVΔ51M produces novel viruses with enhanced antitumor efficacyOmar A Albaradie, Abdulaziz Molham Moglan, Yahya Marwan Samman, et al.
Plos Pathogens|August 24, 2018
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axisChadi Zakaria, Polen Sean, Huy-Dung Hoang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entryTaha Azad, Ragunath Singaravelu, Zaid Taha, et al.
Nature Communications|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapiesTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Molecular Therapy Oncolytics|August 21, 2019
Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer TherapyAdrian Pelin, Johann Foloppe, Julia Petryk, et al.
Nature Microbiology|October 10, 2018
Leveraging single-cell genomics to expand the fungal tree of lifeSteven R Ahrendt, C Alisha Quandt, Doina Ciobanu, et al.
Science Translational Medicine|January 5, 2018
Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapyMarie-Claude Bourgeois-Daigneault, Dominic Guy Roy, Amelia Sadie Aitken, et al.
The New Phytologist|January 14, 2019
Comparative genomics of Rhizophagus irregularis, R. cerebriforme, R. diaphanus and Gigaspora rosea highlights specific genetic features in GlomeromycotinaEmmanuelle Morin, Shingo Miyauchi, Hélène San Clemente, et al.
Journal of Proteome Research|March 3, 2025
Affinity Purification Mass Spectrometry on the Orbitrap-Astral Mass Spectrometer Enables High-Throughput Protein-Protein Interaction MappingLia R Serrano, Adrian Pelin, Tabiwang N Arrey, et al.
International Journal of Molecular Sciences|March 6, 2021
Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD InteractionEmily E F Brown, Reza Rezaei, Taylor R Jamieson, et al.
Frontiers in Molecular Biosciences|May 28, 2026
Tumor-directed evolution of VSVΔ51M produces novel viruses with enhanced antitumor efficacyOmar A Albaradie, Abdulaziz Molham Moglan, Yahya Marwan Samman, et al.
Plos Pathogens|August 24, 2018
Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axisChadi Zakaria, Polen Sean, Huy-Dung Hoang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2021
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entryTaha Azad, Ragunath Singaravelu, Zaid Taha, et al.
Nature Communications|May 26, 2023
Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapiesTaha Azad, Reza Rezaei, Ragunath Singaravelu, et al.
Pageof 4